🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Long life to the DCs in cancer immunotherapy! Congrats David Sancho and collaborators! Nature Communications CNIC ASEICA

New study from CNIC and IRB Barcelona identifies the best dendritic cell subtype to trigger immune memory against #cancer, key to preventing metastasis, via EurekAlert! | EurekAlert! News eurekalert.org/news-releases/…

Una nueva estrategia de inmunoterapia que podría reducir las recaídas en cáncer ha sido desarrollada por el equipo del Dr. David Sancho (David Sancho) (@CNIC_Cardio) con el @irbbarcelona y apoyada por @contracanceres. Este estudio ha demostrado en modelos animales que las células

Great talk by David Sancho shedding light on the role of #dendriticcells in #atherosclerosis: players in shaping immune responses within plaques. #ImmunoAthero meeting

I am delighted to share our latest work, published in Nature Communications: rdcu.be/ejrts Congratulations to my student Irene Herranz and heartfelt thanks to my amazing team and valued collaboration Solip Park

Heras-Murillo et al. treated mice with tumor cell lysate-loaded syngeneic splenic selected cDC populations. bit.ly/4cKkXJp  CNIC  David Sancho

Happy to share the new publication from our lab, identifying a new assembly factor of CI involved in disease!!!‼️🚨#mitochondria Time-resolved mitochondrial screen identifies regulatory components of oxidative metabolism | EMBO reports embopress.org/doi/full/10.10…

We’re excited to announce Hongbo Chi, PhD, as the new Chair of the St. Jude Department of Immunology. His leadership will advance our mission to find cures for catastrophic childhood diseases.

Big shoutout to Brown’s group: IRF8-dependent TC are essential for inducing food-specific pTregs & establishing oral tolerance! In line with recent work from Mucida’s, Littman’s, Gardner’s, and our group highlighting the role of RORγt⁺ APC in this process.rb.gy/rej77q

Incredible! Over the past 2 months, 5 independent manuscripts — from The Colonna Lab, Dan Littman, Gardner Lab and Chrysothemis Brown, and our own (now in nature nature.com/articles/s4158…), reports that the dietary pTreg program is initiated by RORγt⁺ antigen-presenting cells. /1

🚀New breakthrough in the fight against #atherosclerosis 🔬 Researchers from David Sancho group at CNIC discover how cDC1 dendritic cells control inflammation that causes #infarcts and #ictus. In addition, they have developed an experimental therapy with immunosuppressive

Read the full article here 👉 cnic.es/en/noticias/ci…

El CNIC participa en la Jornada Internacional de #Transparencia en experimentación animal #BOARD25, organizada por 𝗘𝗔𝗥𝗔_𝗘𝗦. 🐭🧪 📽️ En este vídeo de la SEBBM el director de investigación básica del #CNIC Vicente Andrés García y David Sancho, jefe de grupo en #CNIC, comparten

Congrats Irene Adán-Barrientos: great thesis presentation & defense CNIC UAM Autónoma Madrid Thx thesis commitee: Julián Aragonés, Arantxa Cruz-Adalia Aranzazu Cruz Adalia lab & Bart Everts Everts Lab on wonderful discussion and visit! Thx Gillian Dunphy Gillian Dunphy on great co-supervision

Congrats, Gabriel Rabinovich It was a pleasure to prepare this preview on your very relevant work showing how GAL1 binds integrins in myeloid cells and triggers immunoregulatory (IL-10) and pro-angiogenic (VEGF) actions that promote tumor growth. GAL1 blockade as new cancer therapy!!!